Cytokines: abnormalities in major depression and implications for pharmacological treatment.
about
Sex-specific association of depression and a haplotype in leukotriene A4 hydrolase geneGlycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeuticsMelancholic microbes: a link between gut microbiota and depression?Gut Microbiota-brain AxisVocal acoustic biomarkers of depression severity and treatment responseEffect of fluoxetine on depression-induced changes in the expression of vasoactive intestinal polypeptide and corticotrophin releasing factor in rat duodenumGene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances.The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.Depression and leukocyte telomere length in patients with coronary heart disease: data from the Heart and Soul Study.The liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis.Functional dyspepsia: are psychosocial factors of relevance?Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression.Influence of the number and severity of somatic symptoms on the severity of depression and suicidality in community-dwelling elders.Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults.The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacologySevere depressive symptoms are associated with elevated endothelin-1 in younger patients with acute coronary syndrome.Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10.What can post-mortem studies tell us about the pathoetiology of suicide?Childhood chronic physical aggression associates with adult cytokine levels in plasma.Differential DNA methylation regions in cytokine and transcription factor genomic loci associate with childhood physical aggressionProinflammatory cytokines in the prefrontal cortex of teenage suicide victims.Interleukin 1B gene (IL1B) variation and internalizing symptoms in maltreated preschoolers.Neuroimmune endocrine effects of antidepressantsThe role of cytokines and hot flashes in perimenopausal depression.The role of dietary polyphenols on adult hippocampal neurogenesis: molecular mechanisms and behavioural effects on depression and anxietyNeural and behavioral responses to low-grade inflammationThe adaptive neuroplasticity hypothesis of behavioral maintenance.Systemic Lupus Erythematous Presenting as Catatonia and its Response to Electroconvulie TherapyNeuroimmune-endocrine crosstalk in schizophrenia and mood disorders.Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis.From gut dysbiosis to altered brain function and mental illness: mechanisms and pathwaysA Biobehavioral [corrected] Framework to Address the Emerging Challenge of Multimorbidity.Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder.Frailty: an emerging research and clinical paradigm--issues and controversies.Neurobiology of major depressive disorderDNA methylation signature of childhood chronic physical aggression in T cells of both men and womenThe Role of Lipid Biomarkers in Major Depression.Neuroimmune pharmacology of neurodegenerative and mental diseases.Serotonin and its implication in the side-effects of interferon-based treatment of patients with chronic viral hepatitis: Pharmacological interventions.A starring role for microglia in brain sex differences.
P2860
Q24615583-8D509ADE-98DF-489B-BD27-B623DEAEA0D7Q24685475-F5D3129C-D82A-4A35-8510-7866ADC3B1F2Q27692537-08CB5150-A5CF-407C-B02F-F29590E05163Q28066767-48DB3330-8FCC-4E57-BDC7-F1DA320E95E3Q30448566-2B21A7AA-2E5A-4CFA-B9B2-CAB087D24A63Q33306239-85A6D082-69F0-40D2-AE43-AF6056DAC0AFQ33329785-147B8CC3-2463-4FA5-A634-965B5A679412Q33868089-65E8D2A6-486E-42C5-9158-74D9A7C5CF0AQ33906570-57A71C5B-4677-49CC-8DC3-5452C4DE3EE9Q33962438-0EE001ED-DDF0-44A4-A132-8B384C78BCB4Q34037402-DA4171E3-F7BC-4AF1-831A-330FE2DC4F53Q34084772-101A6791-5BF8-46E8-8136-A56FBF457E60Q34231839-D4BFD341-EC23-47F5-A68D-CA7D502FB914Q34299973-2FED07AF-EA3A-49E8-9B6A-8AED27C439CFQ34608619-2D12AD3F-B1EA-40F4-AAB7-0EC2C25C4E52Q34613688-199761DE-8F5F-4010-AC5A-ED0EB2DD5976Q34631833-0259C805-B77A-4C62-B401-009F413C1446Q34701742-3BFD5A8B-196A-4011-9EEF-C5349DBC8C24Q34902743-56B949C9-71CC-4C91-8E59-BF58FC4D6F2BQ34971900-7C62E41A-9DD0-46CB-89DF-3AB55D168889Q35573452-B4E3BC49-713A-493D-9680-131FA923FDBDQ35694375-0767510A-AE90-4C3D-8A74-FB73EAFEBDBDQ35758842-F63C0751-C8CF-458E-A0DE-20B1290EF2C6Q35945930-E3A520D1-4CEE-405F-AC45-0D342EA04B84Q36090823-E73F514E-8861-4CCC-8592-F3654613FF00Q36340323-78D4C2F7-A6D5-4AE6-8461-00B4FEA3988EQ36344187-707003EF-CE27-4A3E-A17F-CA6D8E143759Q36364472-067F2374-EFC6-46AE-858E-76BC8973E28DQ36532151-AA4EBF86-7F72-4578-B98B-C734C3834A27Q36576591-BDB6FD5A-60D7-49C3-A9FE-77A2344CC605Q36932850-704ECC58-8051-4BAB-8FCA-7A055C18FA85Q36956374-DC8CE47B-F4B6-41DF-A25B-3019FE9ED9C8Q37083101-D38298A1-D5FF-4D6E-8424-E680FF414B1AQ37104422-78CA1E1F-72C9-43F6-968A-A60C0E8D13F4Q37260128-528D1291-8627-4C1E-8ABF-FE13A08AFFCBQ37514358-A31CB240-FB44-4A02-AD25-9F59754679AEQ37728018-5EFD7558-14F7-4E17-B401-40A3D77B6846Q37785813-75C79596-0AEC-4589-A1ED-39508DF8909EQ38100813-FC3B0B02-7F04-4756-8220-6067F11B2F02Q38215667-8972E0D9-277F-4026-86B8-688155711C6D
P2860
Cytokines: abnormalities in major depression and implications for pharmacological treatment.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cytokines: abnormalities in ma ...... for pharmacological treatment.
@ast
Cytokines: abnormalities in ma ...... for pharmacological treatment.
@en
Cytokines: abnormalities in ma ...... for pharmacological treatment.
@nl
type
label
Cytokines: abnormalities in ma ...... for pharmacological treatment.
@ast
Cytokines: abnormalities in ma ...... for pharmacological treatment.
@en
Cytokines: abnormalities in ma ...... for pharmacological treatment.
@nl
prefLabel
Cytokines: abnormalities in ma ...... for pharmacological treatment.
@ast
Cytokines: abnormalities in ma ...... for pharmacological treatment.
@en
Cytokines: abnormalities in ma ...... for pharmacological treatment.
@nl
P356
P1476
Cytokines: abnormalities in ma ...... for pharmacological treatment
@en
P2093
Lucinda V Scott
Sinead M O'Brien
P304
P356
10.1002/HUP.609
P577
2004-08-01T00:00:00Z